TEBENTAFUSP
UNII N658GY6L3E

Substance Identification & Data

This profile provides standardized clinical and technical data for Tebentafusp, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N658GY6L3E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1874157-95-5 and the RxNorm Concept ID (RxCUI) 2590743. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N658GY6L3E

CAS Registry Number

1874157-95-5

RxNorm Concept ID

2590743

Detailed Substance Profile

Preferred Name

TEBENTAFUSP

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

N658GY6L3E

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C94208

National Cancer Institute reference terminology for clinical and research data.

INN ID

10664

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-27

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tebentafusp. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEBENTAFUSP

TEBENTAFUSP-TEBN

Common Names & Synonyms

T CELL RECEPTOR .ALPHA. CHAIN (SYNTHETIC HUMAN) FUSION PROTEIN WITH T CELL RECEPTOR .BETA. CHAIN (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN) (SYNTHETIC SCFV FRAGMENT)

TEBENTAFUSP [INN]

TEBENTAFUSP [USAN]

TEBENTAFUSP [WHO-DD]

TEBENTAFUSP TEBN [WHO-DD]